These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The detailed clinical objectives approach to designing clinical trials and choosing estimands. Bell J; Hamilton A; Sailer O; Voss F Pharm Stat; 2021 Nov; 20(6):1112-1124. PubMed ID: 34013553 [TBL] [Abstract][Full Text] [Related]
25. Principles and recommendations for incorporating estimands into clinical study protocol templates. Lynggaard H; Bell J; Lösch C; Besseghir A; Rantell K; Schoder V; Lanius V Trials; 2022 Aug; 23(1):685. PubMed ID: 35986349 [TBL] [Abstract][Full Text] [Related]
26. Estimand framework: Are we asking the right questions? A case study in the solid tumor setting. Casey M; Degtyarev E; Lechuga MJ; Aimone P; Ravaud A; Motzer RJ; Liu F; Stalbovskaya V; Tang R; Butler E; Sailer O; Halabi S; George D Pharm Stat; 2021 Mar; 20(2):324-334. PubMed ID: 33155417 [TBL] [Abstract][Full Text] [Related]
27. Estimands and the Patient Journey: Addressing the Right Question in Oncology Clinical Trials. Degtyarev E; Zhang Y; Sen K; Lebwohl D; Akacha M; Hampson LV; Bornkamp B; Maniero A; Bretz F; Zuber E JCO Precis Oncol; 2019 Dec; 3():1-10. PubMed ID: 35100723 [TBL] [Abstract][Full Text] [Related]
29. Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder. Roberts NP; Roberts PA; Jones N; Bisson JI Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010204. PubMed ID: 27040448 [TBL] [Abstract][Full Text] [Related]
30. Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum. Morga A; Latimer NR; Scott M; Hawkins N; Schlichting M; Wang J Value Health; 2023 Feb; 26(2):234-242. PubMed ID: 36150999 [TBL] [Abstract][Full Text] [Related]
31. Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events. Bissonnette R; Eichenfield LF; Simpson E; Thaçi D; Kabashima K; Thyssen JP; Guttman-Yassky E; Nunes FP; Gamalo M; Ahmad F; Kuligowski M; Sun K; Pipper C; Christensen AW; D'Angelo P; Milutinovic M; Guettner A; Silverberg JI J Eur Acad Dermatol Venereol; 2023 May; 37(5):976-983. PubMed ID: 36652273 [TBL] [Abstract][Full Text] [Related]
32. Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example. Hien DA; Campbell AN; Ruglass LM; Saavedra L; Mathews AG; Kiriakos G; Morgan-Lopez A J Subst Abuse Treat; 2015 Sep; 56():23-33. PubMed ID: 25907849 [TBL] [Abstract][Full Text] [Related]
33. A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels? Mitroiu M; Oude Rengerink K; Teerenstra S; Pétavy F; Roes KCB Trials; 2020 Jul; 21(1):671. PubMed ID: 32703247 [TBL] [Abstract][Full Text] [Related]
34. Estimands in cluster-randomized trials: choosing analyses that answer the right question. Kahan BC; Li F; Copas AJ; Harhay MO Int J Epidemiol; 2023 Feb; 52(1):107-118. PubMed ID: 35834775 [TBL] [Abstract][Full Text] [Related]
35. Estimands in clinical trials - broadening the perspective. Akacha M; Bretz F; Ruberg S Stat Med; 2017 Jan; 36(1):5-19. PubMed ID: 27435045 [TBL] [Abstract][Full Text] [Related]
37. Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction. Keene ON Pharm Stat; 2019 Jan; 18(1):78-84. PubMed ID: 30370691 [TBL] [Abstract][Full Text] [Related]
38. Demystifying the estimand framework: a case study using patient-reported outcomes in oncology. Fiero MH; Pe M; Weinstock C; King-Kallimanis BL; Komo S; Klepin HD; Gray SW; Bottomley A; Kluetz PG; Sridhara R Lancet Oncol; 2020 Oct; 21(10):e488-e494. PubMed ID: 33002444 [TBL] [Abstract][Full Text] [Related]
39. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder. Vrana C; Killeen T; Brant V; Mastrogiovanni J; Baker NL Contemp Clin Trials; 2017 Oct; 61():108-114. PubMed ID: 28765006 [TBL] [Abstract][Full Text] [Related]
40. A legal dispute resolution intervention for patients with substance use disorders: a study protocol for a randomized controlled trial. O'Neil MM; Johnson RA; Córdova D; Pryor J; Pinals DA BMC Public Health; 2023 Mar; 23(1):435. PubMed ID: 36879259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]